Cargando…
The flow cytometry-defined light chain cytoplasmic immunoglobulin index and an associated 12-gene expression signature are independent prognostic factors in multiple myeloma
As part of Total Therapy (TT) 3b, baseline marrow aspirates were subjected to two-color flow cytometry of nuclear DNA content and cytoplasmic immunoglobulin (DNA/CIG) as well as plasma cell gene expression profiling (GEP). DNA/CIG-derived parameters, GEP and standard clinical variables were examined...
Autores principales: | Papanikolaou, X, Alapat, D, Rosenthal, A, Stein, C, Epstein, J, Owens, R, Yaccoby, S, Johnson, S, Bailey, C, Heuck, C, Tian, E, Joiner, A, van Rhee, F, Khan, R, Zangari, M, Jethava, Y, Waheed, S, Davies, F, Morgan, G, Barlogie, B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530205/ https://www.ncbi.nlm.nih.gov/pubmed/25753926 http://dx.doi.org/10.1038/leu.2015.65 |
Ejemplares similares
-
Flow cytometry defined cytoplasmic immunoglobulin index is a major prognostic factor for progression of asymptomatic monoclonal gammopathies to multiple myeloma (subset analysis of SWOG S0120)
por: Papanikolaou, X, et al.
Publicado: (2016) -
Dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myeloma
por: Jethava, Y, et al.
Publicado: (2016) -
Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myeloma
por: Jethava, Y, et al.
Publicado: (2016) -
Combination of Flow Cytometry and Functional Imaging for Monitoring
of Residual Disease in Myeloma
por: Rasche, L, et al.
Publicado: (2018) -
The Clinical Value of Molecular Subtyping Multiple Myeloma Using Gene Expression Profiling
por: Weinhold, N, et al.
Publicado: (2015)